JENNIFER REPSHIS: Open Payments
NPI 1568456754 · PLAINS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,566 in 205 payments from 35 companies in 2025. Trend: 2023 $1,560 · 2024 $1,778 · 2025 $3,566
Food & beverage: $3,566
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $453 |
| Bayer Healthcare Pharmaceuticals Inc. | 20 | $386 |
| Amgen Inc. | 24 | $330 |
| AstraZeneca Pharmaceuticals LP | 11 | $291 |
| Lilly USA, LLC | 21 | $287 |
| PFIZER INC. | 14 | $203 |
| Aimmune Therapeutics, Inc. | 10 | $188 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $152 |
| Otsuka America Pharmaceutical, Inc. | 5 | $109 |
Products named: Kerendia, VRAYLAR, MOUNJARO, REXULTI, ZENPEP, OTEZLA, AIRSUPRA, XIFAXAN.
Industry payments across PA — which companies pay providers there.
